Fact CheckerSign in

NCT06020378Active, not recruiting

Hydroxychloroquine May be Beneficial for Preeclampsia

Hydroxychloroquine Treatment During Pregnancy is Associated With Lower Risk of Preeclampsia in Patients With Recurrent Spontaneous Abortion of Unknown Aetiology

Source: ClinicalTrials.gov · Last updated 24 Apr 2025

Brief summary (registry, in English)

The purpose of this research is to investigate the impact of hydroxychloroquine on the incidence of hypertensive pregnancy disorders in women with a history of recurrent spontaneous abortion (RSA).

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
462 (actual)
First submitted
7 Aug 2023
Start date
1 Jan 2024
Primary completion date
1 Jul 2026
Lead sponsor
RenJi Hospital
NCT number
NCT06020378

What you commit to

  • Study type: Observational
  • Participants enrolled: 462
  • From 1 Jan 2024 to the primary completion date, 1 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • indication to a treatment according to the severe cardiovascular, immune, respiratory, gastrointestinal/liver and biliary system, kidney and urinary system, nervous system, musculoskeletal system, psychiatric, infectious disease, malignancy,
  • Maternal endocrine dysfunction: premature ovarian failure, hyperprolactinemia, corpus luteal insufficiency, untreated diabetes mellitus or untreated thyroid dysfunction.

Other

  • major malformation of the fetus diagnosed at 11-13 weeks of gestation.
  • Known paternal, maternal, or embryo chromosome abnormality;
  • Abnormal uterine anatomy at hysterosalpingography/hysteroscopy or hydrosonography that might explain RM in the first trimester of pregnancy;

Who the study is looking for

  • singleton pregnant women
  • with a history of two or more miscarriages

Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shanghai Jiao Tong University School of Medicine, Renji Hospital
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.